Lime Posts Record Q2 Revenue of $304M and Guides Q3 to $340M–$360M
LIME sits 34% above its 52-week low of $23.873.
Summary
Lime posted record Q2 revenue of $304M (+24% YoY) and guided Q3 revenue to $340M–$360M, with full-year Adjusted EBITDA of $265M–$285M. The company also paid down all long-term debt and acquired Neuron Mobility's Canadian operations.
Key Events · Earnings and Guidance · LIME
-
Record Q2 Revenue of $304M
Revenue grew 24% year-over-year to $304 million, driven by a 22% increase in average operational fleet to 407,707 vehicles.
-
Strong Profitability Metrics
Adjusted EBITDA reached $84 million, a 28% margin, while net income of $295 million included a one-time tax benefit from releasing a valuation allowance.
-
Upbeat Q3 and Full-Year Guidance
Q3 revenue is expected between $340 million and $360 million, with Adjusted EBITDA of $120 million to $130 million. Full-year revenue is guided to $1.04 billion to $1.10 billion, with Adjusted EBITDA of $265 million to $285 million.
-
Balance Sheet Strengthened
IPO proceeds were used to pay down all outstanding long-term debt, and the company acquired Neuron Mobility's Canadian operations, expanding its footprint.
Analysis · LIME · Technology
In its first quarter as a public company, Lime delivered a standout performance with record revenue of $304 million, up 24% year-over-year, and issued strong guidance for Q3 and full-year 2026. A 22% expansion in the average operational fleet helped drive the top line, while a one-time tax benefit pushed net income to $295 million. Underlying profitability also improved, with Adjusted EBITDA reaching $84 million—a 28% margin. The company deployed IPO proceeds to retire all long-term debt and, subsequent to quarter end, expanded into Canada through the acquisition of Neuron Mobility's operations. The guidance implies accelerating growth and margin expansion, reinforcing the investment thesis.
At the time of this filing, LIME was trading at $32.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $2B. The 52-week trading range was $23.87 to $32.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.